Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ISCPRISMS: No Benefit of tPA in Mild Stroke Without Disability In the PRISMS trial, thrombolysis provided no benefit in the number of patients achieving good outcomes after a mild stroke without disabling deficits and increased risk for symptomatic intracerebral hemorrhage.
Medscape Medical News, January 31, 2018
ISCRivaroxaban Plus Aspirin Cuts Stroke Rate in Half New results from the COMPASS trial show combination therapy reduced the ischemic stroke rate by 49% vs aspirin alone in patients with stable vascular disease, without increasing intracerebral bleeding.
Top News From ISC 2018: SlideshowHighlights include new stroke guidelines that extend thrombectomy to 24 hours, tenecteplase tops alteplase for stroke thrombolysis,
and electrical stimulation eases stroke dysphagia.
PREMIER: Flow Diversion Effective for Small AneurysmsResults of a new trial show high occlusion and low retreatment rates of intracranial aneurysms approximately 7 mm in size
with the Pipeline Embolization Device, already approved for larger aneurysms.
Midlife Vascular Risk Factors Drive Dementia Later in LifeVascular risk factors present in midlife raise the risk for dementia later in life, new research confirms. Diabetes is associated
with an Alzheimer's risk as high as that seen with carrying the APOE epsilon-4 allele.
